A qualitative study to evaluate patients’, carers’ and doctors’ opinions on blood biomarker tests to monitor the treatment of oesophageal, gastric and colorectal cancers

Flinders Medical Centre0 sites120 target enrollmentJanuary 24, 2022

Overview

No summary available.

Registry

who.int

Start Date

January 24, 2022

End Date

TBD

Last Updated

2 years ago

Study Type

Observational

Sex

All

Sponsor

•Participants, carers and clinicians who fit the following criteria will be invited into the study:
•1\)be over 18 years of age and be willing to participate in a focus group either in person at the Flinders Centre for Innovation in Cancer (Bedford Park, South Australia), or be able to participate in group discussion via a web\-based format e.g. Microsoft Teams or Zoom.
•2\)have undergone treatment (within the previous 3 years) of stomach, oesophageal or bowel cancer, OR have supported someone who has a history of one of these cancers, OR work in a clinical role providing clinical care for patients with these cancers.

•Participants will be excluded if:
•1\)They are in the palliative phase of their cancer;
•2\)Have any underlying conditions (e.g., anxiety/depression) where discussing their diagnosis and treatment might exacerbate any symptoms.
•Participants, carers or clinicians will be excluded if:
•1\)They have a perceived or actual conflict of interest relating to any blood biomarker tests.